media – Page 430 – DrugDu- Global Leading Pharmaceutical & Medical Device Platform

Study outlines concerns around natural psychoactive substances

Source : https://www.medicalnewstoday.com/articles/327192.php#1 Medical news today New research finds that over a period of 17 years, people in the United States increased their use of natural psychoactive substances, believing them to be safe. This has led to many reports of adverse symptoms in adults and children alike.People have been using natural psychoactive substances for hundreds or even thousands, of years in traditional medicine and as a part of spiritual practices. Because these substances come from sources such as plants and mushrooms, many people believe them to be safe to use.However, because they interfere with biological processes in the central nervous system, they can be a threat to human health. These interferences can also cause euphoria and altered states of consciousness. The Center for Injury Research and Policy at the Research Institute at Nationwide Children’s Hospital in Columbus, OH, collaborated with the Ohio State University College of Medicine, also in Columbus, to ...
- Source: drugdu
- 262
- December 4, 2019
How a virus might protect against skin cancer

Nov.19 2019 source: https://www.medicalnewstoday.com/articles/326967.php#1 Medical News Today Previously, scientists have linked the presence of human papillomavirus to an increased risk of certain cancers. In a surprising twist, the latest research finds that the virus might help defend against skin cancer. There are more than 100Trusted Source strains of human papillomavirus (HPV), only a handful of which experts consider to be a risk to human health. Scientists have linked these strains with an increased risk of certain cancers, including those of the cervix, vulva, penis, and anus. Of the remaining strains of HPV, many are little more than harmless stowaways on our skin. These so-called commensal viruses are the subject of scrutiny for a group of researchers at Massachusetts General Hospital in Boston. The scientists recently published a paper in NatureTrusted Source, which concludes that immunity to these HPV strains may protect against skin cancer.
- Source: drugdu
- 209
- November 25, 2019
How a virus might protect against skin cancer

Source : Medical News Today https://www.medicalnewstoday.com/articles Previously, scientists have linked the presence of human papillomavirus to an increased risk of certain cancers. In a surprising twist, the latest research finds that the virus might help defend against skin cancer. There are more than 100Trusted Source strains of human papillomavirus (HPV), only a handful of which experts consider to be a risk to human health.Scientists have linked these strains with an increased risk of certain cancers, including those of the cervix, vulva, penis, and anus.Of the remaining strains of HPV, many are little more than harmless stowaways on our skin.These so-called commensal viruses are the subject of scrutiny for a group of researchers at Massachusetts General Hospital in Boston.The scientists recently published a paper in NatureTrusted Source, which concludes that immunity to these HPV strains may protect against skin cancer.
- Source: drugdu
- 213
- November 19, 2019
Fasenra Granted US Orphan Drug Designation for Eosinophilic Oesophagitis

AstraZeneca today announced that the US Food and Drug Administration (FDA) has granted Orphan Drug Designation (ODD) to Fasenra (benralizumab) for the treatment of eosinophilic oesophagitis (EoE). EoE is a rare, chronic, inflammatory disease that occurs when eosinophils, a type of white blood cell, accumulate in the oesophagus causing injury and inflammation. The FDA grants ODD status to medicines and potential new medicines intended for the treatment, diagnosis or prevention of rare diseases or disorders that affect fewer than 200,000 people in the US. About Fasenra Fasenra (benralizumab) is a monoclonal antibody that binds directly to the IL-5 receptor alpha on eosinophils and attracts natural killer cells to induce rapid and near-complete depletion of eosinophils via apoptosis (programmed cell death). Fasenra is AstraZeneca’s first respiratory biologic, now approved as an add-on maintenance treatment in severe eosinophilic asthma in the US, EU, Japan and other countries, with further regulatory reviews ongoing. In June 2019, the European Medicines ...
- Source: drugdu
- 763
- October 8, 2019
AstraZeneca Orphan Drug
Ebola ‘no longer incurable’

By Anna Smith A new study in the BMJ has identified two new drugs, mAb114 and REGN-EB3, that can dramatically cut mortality from Ebola, and both are being immediately offered to all patients in an effort to control the Democratic Republic of Congo’s (DRC) worst-ever outbreak. The trial initially compared four potential treatments proposed by four different companies: ZMapp, remdesivir, mAb114, and REGN-EB3, and preliminary data convinced the trial’s monitoring board to stop the study and randomize all remaining patients to either mAb114 or REGN-EB3. Data from the first 499 patients showed that REGN-EB3 had met early stopping criteria, and mAb114 was ‘not far behind’. Among all patients who took the drugs, those treated with REGN-EB3 had a mortality rate of 29%, while those who got mAb-114 had a mortality rate of 34%. Both drugs are monoclonal antibodies, proteins that bind to other proteins on the outer shell of the Ebola ...
- Source: drugdu
- 606
- August 15, 2019
Ebola
Genentech Announces Positive Results for First Global Phase III Study Investigating One-dose XOFLUZA (Baloxavir Marboxil) in Children With the Flu

– The MINISTONE-2 study showed XOFLUZA, given as a new oral suspension, is a well-tolerated and effective potential treatment for the flu in otherwise healthy children aged one to less than 12 years – – Approximately one in three children develop the flu every year and they are often contagious longer than adults – treating children may therefore help reduce symptoms and prevent the spread of the flu to the wider community – SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)–Jul. 3, 2019– Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), today announced that the Phase III MINISTONE-2 study met its primary endpoint, demonstrating that XOFLUZA™ (baloxavir marboxil) was well-tolerated in children with the flu. The study also showed that XOFLUZA is comparable to oseltamivir – a proven effective treatment for children with the flu – at reducing the duration of flu symptoms, including fever. The study assessed XOFLUZA versus ...
- Source: drugdu
- 1,367
- August 2, 2019
flu Roche Xofluza
Proof-of-concept system uses smart speakers to catch signs of cardiac arrest

Author: Dave Muoio In an effort to tackle in-home cardiac arrest, University of Washington researchers have devised a novel contactless system that uses smartphones or voice-based personal assistants to identify telltale breathing patterns that accompany an attack. The proof-of-concept strategy, described in an NPJ Digital Medicine paper published this morning, involved a supervised machine learning model called a support-vector machine that was trained for use in the bedroom, a controlled environment in which the majority of in-home cardiac arrests occur. “Sometimes reported as ‘gasping’ breaths, agonal respirations may hold potential as an audible diagnostic biomarker, particularly in unwitnessed cardiac arrests that occur in a private residence, the location of [two-thirds] of all [out-of-hospital cardiac arrests],” the researchers wrote. “The widespread adoption of smartphones and smart speakers (projected to be in 75% of US households by 2020) presents a unique opportunity to identify this audible biomarker and connect unwitnessed ...
- Source: drugdu
- 907
- July 8, 2019
algorithm cardiac arrest contactless monitoring heart attack passive monitoring remote monitoring University of Washington
How Central, East Africa’s tech renaissance is shaping its healthcare future

Link：https://www.mobihealthnews.com/content/how-central-east-africas-tech-renaissance-shaping-its-healthcare-future
- Source: drugdu
- 920
- June 4, 2019
Africa EHRs healthcare
WiFi may interact with signaling pathways in the brain, causing irreversible damage

A recent study reviewed evidence from 23 controlled scientific studies which investigated the health effects of WiFi on animals, human cell lines, and humans to determine once and for all, whether WiFi has a detrimental effect on human health.
- Source: https://www.news-medical.net/news/20190418/WiFi-may-interact-with-signaling-pathways-in-the-brain-causing-irreversible-damage.aspx
- 611
- May 20, 2019
brain exposure WiFi
World Immunization Week 2019

Theme: #VaccinesWork World Immunization Week – celebrated in the last week of April – aims to promote the use of vaccines to protect people of all ages against disease. Immunization saves millions of lives every year and is widely recognized as one of the world’s most successful and cost-effective health interventions. Yet, there are still nearly 20 million unvaccinated and under-vaccinated children in the world today. The theme this year is Protected Together: Vaccines Work!, and the campaign will celebrate Vaccine Heroes from around the world – from parents and community members to health workers and innovators – who help ensure we are all protected through the power of vaccines. Vast progress but fragile gains In 2017, the number of children immunized – 116.2 million – was the highest ever reported. Since 2010, 113 countries have introduced new vaccines, and more than 20 million additional children have been vaccinated. But despite gains, all ...
- Source: drugdu
- 1,141
- May 16, 2019
health vaccine WHO

your submission has already been received.

OK

Subscribe

Please enter a valid Email address！

Submit

The most relevant industry news & insight will be sent to you every two weeks.

more

more

Customer Services
Contact Us
Help Center

Buy on Drugdu.com
Browse Product Categories

Free APP

Follow Us

Terms & Conditions | Privacy Policy

粤ICP备16008861号

Copyright © 2016-2018 Drugdu.com. All Rights Reserved.